You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

Xpert Xpress SARS-CoV-2 Test

News Releases

Cepheid to Webcast Upcoming Financial Presentations

SUNNYVALE, Calif., Nov. 2, 2010 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.

Credit Suisse Healthcare Conference, Phoenix, AZ

Thursday, November 11, 2010 at 4.30 p.m. Mountain Time

Lazard Healthcare Conference, New York, NY

Tuesday, November 16, 2010 at 2.40 p.m. Eastern Time

Stephens Fall Investment Conference, New York, NY

Wednesday, November 17, 2010 at 11.00 a.m. Eastern Time

Piper Jaffray Health Care Conference, New York, NY

Tuesday, November 30, 2010 at 9.30 a.m. Eastern Time

NASDAQ OMX 25th Investor Program, London, England

Tuesday, December 7, 2010 at 10.45 a.m. Greenwich Mean Time

To access the live webcasts for these events, please visit Cepheid's website at at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcasts will be available shortly following the presentations and will remain available for at least 90 days.

About Cepheid

Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit


For Media Inquiries:

For Investor Inquiries:

Jared Tipton

Cepheid Corporate Communications

Tel: (408) 400-8377

Jacquie Ross

Cepheid Investor Relations

Tel: (408) 400-8329

SOURCE Cepheid

For further information: Media Inquiries, Jared Tipton, Corporate Communications, +1-408-400-8377,; or Investor Inquiries, Jacquie Ross, Investor Relations, +1-408-400-8329,, both of Cepheid
Back to Top